NEW YORK (GenomeWeb News) — Celera is cutting back its proteomics research staff at its facility in Rockville, Md., as the company gradually evolves into a diagnostics developer, GenomeWeb Daily News has learned.
 
Company spokesman David Speechly confirmed that Celera is “trimming” its staff in proteomics research but would not provide details. He said the job cuts are part of a strategic shift that includes cutting out proteomics research but continuing to use proteomics resources for clinical development.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.